NCT02946580View on ClinicalTrials.gov

Naloxegol for the Prevention of Constipation in Postoperative Spinal Surgery Patients

PHASE4TerminatedINTERVENTIONAL

Enrollment

53

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions

Constipation

Interventions

DRUG

MOVANTIK™ (naloxegol)

DRUG

Sugar Pill

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Massachusetts General Hospital

OTHER